Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 22, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	61,987	81,587	78,071	96,085	79,075	68,631
Market Cap Growth	18.40%	4.50%	-18.75%	21.51%	15.22%	33.09%
Enterprise Value	46,221	75,687	71,763	87,943	74,034	65,636
Last Close Price	609.27	771.87	712.33	878.29	721.49	631.52
PE Ratio	14.85	18.61	18.58	25.26	18.88	8.77
Forward PE	12.58	17.11	15.19	19.36	17.29	11.00
PEG Ratio	1.16	2.93	0.95	4.75	-	-
PS Ratio	4.16	5.69	5.50	7.33	6.50	4.27
PB Ratio	1.98	2.61	2.66	3.70	3.49	3.66
P/TBV Ratio	2.18	2.79	2.91	4.01	3.77	3.78
P/FCF Ratio	15.09	19.99	21.30	24.79	17.87	10.51
P/OCF Ratio	12.38	16.39	17.66	20.92	15.77	9.69
EV/Sales Ratio	3.10	5.28	5.05	6.70	6.08	4.08
EV/EBITDA Ratio	10.55	18.36	16.04	19.68	14.57	7.11
EV/EBIT Ratio	12.03	21.15	17.98	21.73	15.62	7.34
EV/FCF Ratio	11.24	18.55	19.58	22.69	16.73	10.05
Debt / Equity Ratio	0.06	0.09	0.09	0.10	0.12	0.11
Debt / EBITDA Ratio	0.65	0.66	0.61	0.61	0.53	0.29
Debt / FCF Ratio	0.66	0.66	0.74	0.70	0.61	0.41
Net Debt / Equity Ratio	-0.19	-0.19	-0.21	-0.31	-0.22	-0.16
Net Debt / EBITDA Ratio	-1.45	-1.43	-1.41	-1.82	-0.99	-0.32
Net Debt / FCF Ratio	-1.47	-1.45	-1.72	-2.10	-1.14	-0.46
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.75
Inventory Turnover	0.73	0.67	0.70	0.73	0.72	1.26
Quick Ratio	2.84	3.28	3.86	4.82	4.16	2.98
Current Ratio	3.57	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.11%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	7.65%	7.87%	10.40%	12.23%	15.49%	36.37%
Return on Invested Capital (ROIC)	11.02%	11.50%	16.48%	20.01%	23.65%	54.51%
Return on Capital Employed (ROCE)	10.09%	10.22%	12.57%	14.52%	19.92%	49.75%
Earnings Yield	7.13%	5.37%	5.38%	3.96%	5.30%	11.40%
FCF Yield	6.63%	5.00%	4.69%	4.03%	5.60%	9.51%
Dividend Yield	0.62%	0.46%	0.00%	0.00%	0.00%	0.00%
Payout Ratio	8.86%	8.22%	0.00%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	5.61%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	6.23%	6.11%	-1.23%	-0.18%	-1.16%	2.52%

SEC Filings: 10-K · 10-Q